JP2019068852A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019068852A5 JP2019068852A5 JP2019006734A JP2019006734A JP2019068852A5 JP 2019068852 A5 JP2019068852 A5 JP 2019068852A5 JP 2019006734 A JP2019006734 A JP 2019006734A JP 2019006734 A JP2019006734 A JP 2019006734A JP 2019068852 A5 JP2019068852 A5 JP 2019068852A5
- Authority
- JP
- Japan
- Prior art keywords
- vector
- polypeptide
- vaccine composition
- protein
- mutation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15181791.3 | 2015-08-20 | ||
| EP15181791 | 2015-08-20 | ||
| EP16156334.1 | 2016-02-18 | ||
| EP16156334 | 2016-02-18 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018509566A Division JP6470872B2 (ja) | 2015-08-20 | 2016-08-18 | 治療用ｈｐｖ１８ワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019068852A JP2019068852A (ja) | 2019-05-09 |
| JP2019068852A5 true JP2019068852A5 (https=) | 2019-10-03 |
| JP6748240B2 JP6748240B2 (ja) | 2020-08-26 |
Family
ID=56787465
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018509566A Expired - Fee Related JP6470872B2 (ja) | 2015-08-20 | 2016-08-18 | 治療用ｈｐｖ１８ワクチン |
| JP2019006734A Expired - Fee Related JP6748240B2 (ja) | 2015-08-20 | 2019-01-18 | 治療用ｈｐｖ１８ワクチン |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018509566A Expired - Fee Related JP6470872B2 (ja) | 2015-08-20 | 2016-08-18 | 治療用ｈｐｖ１８ワクチン |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US9790256B2 (https=) |
| EP (1) | EP3337500A1 (https=) |
| JP (2) | JP6470872B2 (https=) |
| KR (1) | KR20180042295A (https=) |
| CN (1) | CN107921110B (https=) |
| AU (2) | AU2016309743B2 (https=) |
| BR (1) | BR112018003019A2 (https=) |
| CA (1) | CA2995740A1 (https=) |
| CL (1) | CL2018000432A1 (https=) |
| CO (1) | CO2018001623A2 (https=) |
| EA (1) | EA037295B1 (https=) |
| HK (1) | HK1252967A1 (https=) |
| IL (1) | IL257604A (https=) |
| JO (1) | JO3765B1 (https=) |
| MX (1) | MX2018002106A (https=) |
| MY (1) | MY195389A (https=) |
| SA (1) | SA518390954B1 (https=) |
| SG (1) | SG10202001501QA (https=) |
| TW (1) | TWI744246B (https=) |
| WO (1) | WO2017029360A1 (https=) |
| ZA (2) | ZA201801119B (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE040440T2 (hu) | 2014-11-04 | 2019-03-28 | Janssen Vaccines & Prevention Bv | Terápiás HPV16-oltóanyagok |
| KR20180042295A (ko) | 2015-08-20 | 2018-04-25 | 얀센 백신스 앤드 프리벤션 비.브이. | 치료용 hpv18 백신 |
| EP3452087A1 (en) | 2016-05-02 | 2019-03-13 | Janssen Vaccines & Prevention B.V. | Therapeutic hpv vaccine combinations |
| EP3518966A1 (en) | 2016-09-29 | 2019-08-07 | GlaxoSmithKline Biologicals S.A. | Compositions and methods of treatment of persistent hpv infection |
| TW201923084A (zh) * | 2017-09-23 | 2019-06-16 | 德商百靈佳殷格翰維美迪加股份有限公司 | 副黏液病毒科(paramyxoviridae)表現系統 |
| EP3461497A1 (en) * | 2017-09-27 | 2019-04-03 | GlaxoSmithKline Biologicals S.A. | Viral antigens |
| WO2019151760A1 (ko) * | 2018-02-02 | 2019-08-08 | 주식회사 에스엘백시젠 | 신규 다가 hpv 백신 조성물 |
| US11713469B2 (en) * | 2018-07-20 | 2023-08-01 | Janssen Vaccines & Prevention B.V. | Recombinant adenoviral vector expressing Zika antigen with improved productivity |
| TWI852977B (zh) | 2019-01-10 | 2024-08-21 | 美商健生生物科技公司 | 前列腺新抗原及其用途 |
| CA3128973A1 (en) | 2019-03-04 | 2020-09-10 | Bhaskar Bhattacharyya | Data compression and communication using machine learning |
| JP7732977B2 (ja) | 2019-09-20 | 2025-09-02 | トランスジーン | Ｈｐｖポリペプチドおよびｉｌ－２をコードするポックスウイルスと抗ｐｄ－ｌ１抗体の組合せ |
| KR20220115569A (ko) | 2019-11-18 | 2022-08-17 | 얀센 바이오테크 인코포레이티드 | 돌연변이 calr 및 jak2에 기반한 백신 및 이의 용도 |
| TW202144388A (zh) | 2020-02-14 | 2021-12-01 | 美商健生生物科技公司 | 在卵巢癌中表現之新抗原及其用途 |
| TW202144389A (zh) | 2020-02-14 | 2021-12-01 | 美商健生生物科技公司 | 在多發性骨髓瘤中表現之新抗原及其用途 |
| WO2021202949A2 (en) * | 2020-04-02 | 2021-10-07 | Inovio Pharmaceuticals, Inc. | Compositions and methods for treating vulvar dysplasia |
| EP4135757A1 (en) | 2020-04-13 | 2023-02-22 | Janssen Biotech, Inc. | Psma and steap1 vaccines and their uses |
| EP4149530A1 (en) | 2020-05-12 | 2023-03-22 | Janssen Vaccines & Prevention B.V. | Administration of homologous adenoviral vectors |
| US12295997B2 (en) | 2020-07-06 | 2025-05-13 | Janssen Biotech, Inc. | Prostate neoantigens and their uses |
| US12275766B2 (en) | 2020-12-23 | 2025-04-15 | Janssen Biotech, Inc. | Neoantigen peptide mimics |
| JP2024539188A (ja) * | 2021-10-22 | 2024-10-28 | イノビオ ファーマシューティカルズ，インコーポレイティド | 肛門高悪性度扁平上皮内病変（ｈｓｉｌ）を治療するための組成物及び方法 |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0173552B1 (en) | 1984-08-24 | 1991-10-09 | The Upjohn Company | Recombinant dna compounds and the expression of polypeptides such as tpa |
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| NZ230747A (en) | 1988-09-30 | 1992-05-26 | Bror Morein | Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina |
| HU212924B (en) | 1989-05-25 | 1996-12-30 | Chiron Corp | Adjuvant formulation comprising a submicron oil droplet emulsion |
| FR2705686B1 (fr) | 1993-05-28 | 1995-08-18 | Transgene Sa | Nouveaux adénovirus défectifs et lignées de complémentation correspondantes. |
| JP3816518B2 (ja) | 1994-06-10 | 2006-08-30 | ジェンベク、インコーポレイティッド | 相補的なアデノウイルスベクター系と細胞系 |
| US5851806A (en) | 1994-06-10 | 1998-12-22 | Genvec, Inc. | Complementary adenoviral systems and cell lines |
| US5559099A (en) | 1994-09-08 | 1996-09-24 | Genvec, Inc. | Penton base protein and methods of using same |
| US5846782A (en) | 1995-11-28 | 1998-12-08 | Genvec, Inc. | Targeting adenovirus with use of constrained peptide motifs |
| US5965541A (en) | 1995-11-28 | 1999-10-12 | Genvec, Inc. | Vectors and methods for gene transfer to cells |
| US5786464C1 (en) | 1994-09-19 | 2012-04-24 | Gen Hospital Corp | Overexpression of mammalian and viral proteins |
| AUPM873294A0 (en) | 1994-10-12 | 1994-11-03 | Csl Limited | Saponin preparations and use thereof in iscoms |
| SI0833934T2 (sl) | 1995-06-15 | 2013-04-30 | Crucell Holland B.V. | Pakirni sistemi za humani rekombinantni adenovirus za uporabo v genski terapiji |
| US5837511A (en) | 1995-10-02 | 1998-11-17 | Cornell Research Foundation, Inc. | Non-group C adenoviral vectors |
| US5891690A (en) | 1996-04-26 | 1999-04-06 | Massie; Bernard | Adenovirus E1-complementing cell lines |
| CA2283253A1 (en) | 1997-03-04 | 1998-09-11 | Baxter International Inc. | Adenovirus e1-complementing cell lines |
| US6020191A (en) | 1997-04-14 | 2000-02-01 | Genzyme Corporation | Adenoviral vectors capable of facilitating increased persistence of transgene expression |
| US5972650A (en) | 1997-06-26 | 1999-10-26 | Brigham And Women's Hospital | Tetracycline repressor regulated mammalian cell transcription and viral replication switch |
| US5981225A (en) | 1998-04-16 | 1999-11-09 | Baylor College Of Medicine | Gene transfer vector, recombinant adenovirus particles containing the same, method for producing the same and method of use of the same |
| US6113913A (en) | 1998-06-26 | 2000-09-05 | Genvec, Inc. | Recombinant adenovirus |
| ATE519855T1 (de) | 1999-05-17 | 2011-08-15 | Crucell Holland Bv | Rekombinantes adenovirus des serotyps ad11 |
| US6913922B1 (en) | 1999-05-18 | 2005-07-05 | Crucell Holland B.V. | Serotype of adenovirus and uses thereof |
| FR2794370B1 (fr) | 1999-06-03 | 2003-10-17 | Biovector Therapeutics | Fragments proteiques polyepitopiques, leur obtention et leurs utilisations notamment en vaccination |
| DE19955558C2 (de) | 1999-11-18 | 2003-03-20 | Stefan Kochanek | Permanente Amniozyten-Zelllinie, ihre Herstellung und Verwendung zur Herstellung von Gentransfervektoren |
| AU1152402A (en) | 2000-10-04 | 2002-04-15 | Univ Pennsylvania | Highly expressible genes |
| ATE452972T1 (de) | 2001-05-01 | 2010-01-15 | Ca Nat Research Council | Induzierbares expressionssystem in eukaryotischen zellen |
| KR101021387B1 (ko) | 2002-04-25 | 2011-03-14 | 크루셀 홀란드 비.브이. | 아데노바이러스 벡터를 생산하기 위한 수단 및 방법 |
| SE0202110D0 (sv) | 2002-07-05 | 2002-07-05 | Isconova Ab | Iscom preparation and use thereof |
| SE0301998D0 (sv) | 2003-07-07 | 2003-07-07 | Isconova Ab | Quil A fraction with low toxicity and use thereof |
| AU2005222776A1 (en) * | 2003-12-31 | 2005-09-29 | Genimmune N.V. | Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
| NZ548495A (en) | 2004-02-23 | 2009-05-31 | Crucell Holland Bv | Virus purification methods |
| EP1809750B1 (en) | 2004-11-08 | 2012-03-21 | ChromaGenics B.V. | Selection of host cells expressing protein at high levels |
| CN1796403B (zh) * | 2004-12-22 | 2010-04-28 | 三峡大学 | 用于多型人乳头瘤病毒感染防治的多肽和疫苗 |
| WO2007073513A2 (en) | 2005-11-10 | 2007-06-28 | Genvec, Inc. | Method for propagating adenoviral vectors encoding inhibitory gene products |
| DK1996238T3 (da) | 2006-02-28 | 2016-08-01 | Vaxart Inc | Kimæriske adenovirale vektorer og DsRNA som TLR3-agonist |
| US20100143302A1 (en) | 2006-03-16 | 2010-06-10 | Crucell Holland B.V. | Recombinant Adenoviruses Based on Serotype 26 and 48, and Use Thereof |
| CN101100672B (zh) * | 2007-06-06 | 2010-05-26 | 曾毅 | 经修饰的hpv e6-e7融合基因及其编码蛋白 |
| DE102008010954A1 (de) * | 2008-02-25 | 2009-08-27 | Cichon, Günter, Prof.Dr. | DNA-Vakzine zur Therapie und Prophylaxe von Gebärmutterhalskrebs und seinen prämalignen Vorstufen |
| CN101591646B (zh) * | 2008-05-27 | 2012-05-30 | 清华大学深圳研究生院 | 一种治疗人宫颈癌的树突状细胞疫苗 |
| CN102203242B (zh) | 2008-11-03 | 2013-06-12 | 克鲁塞尔荷兰公司 | 产生腺病毒载体的方法 |
| GB0823497D0 (en) | 2008-12-24 | 2009-01-28 | Isis Innovation | Immunogenic composition and use thereof |
| MX2012007936A (es) | 2010-02-15 | 2012-11-22 | Crucell Holland Bv | Metodo para la produccion de vectores adenovirales del serotipo 26 del adenovirus. |
| US20130064849A1 (en) * | 2011-07-14 | 2013-03-14 | The Board Of Regents Of The University Of Texas | Methods to treat and prevent cardiovascular disease using human papillomavirus vaccines |
| WO2013074501A1 (en) | 2011-11-14 | 2013-05-23 | Crucell Holland B.V. | Heterologous prime-boost immunization using measles virus-based vaccines |
| EP2601968A1 (en) * | 2011-12-06 | 2013-06-12 | Deutsches Krebsforschungszentrum | HPV derived polynucleic acids for therapy |
| BR112014015016B1 (pt) * | 2011-12-21 | 2023-10-03 | Nykode Therapeutics ASA | Proteína homodimérica de duas cadeias de aminoácidos idênticas,cadeia de aminoácido, molécula de ácido nucléico, composição farmacêutica,célula hospedeira, método de preparação de uma proteína homodimérica, método de preparação de uma vacina e vacina |
| US8932607B2 (en) | 2012-03-12 | 2015-01-13 | Crucell Holland B.V. | Batches of recombinant adenovirus with altered terminal ends |
| US9119813B2 (en) | 2012-03-22 | 2015-09-01 | Crucell Holland B.V. | Vaccine against RSV |
| CN103864936B (zh) * | 2012-12-11 | 2018-01-23 | 中国疾病预防控制中心病毒病预防控制所 | Hpv18型l2ne7e6融合蛋白基因、表达载体、方法、菌株和用途 |
| HUE040440T2 (hu) | 2014-11-04 | 2019-03-28 | Janssen Vaccines & Prevention Bv | Terápiás HPV16-oltóanyagok |
| KR20180042295A (ko) | 2015-08-20 | 2018-04-25 | 얀센 백신스 앤드 프리벤션 비.브이. | 치료용 hpv18 백신 |
-
2016
- 2016-08-18 KR KR1020187007319A patent/KR20180042295A/ko not_active Withdrawn
- 2016-08-18 BR BR112018003019A patent/BR112018003019A2/pt not_active Application Discontinuation
- 2016-08-18 AU AU2016309743A patent/AU2016309743B2/en not_active Ceased
- 2016-08-18 CA CA2995740A patent/CA2995740A1/en active Pending
- 2016-08-18 JP JP2018509566A patent/JP6470872B2/ja not_active Expired - Fee Related
- 2016-08-18 SG SG10202001501QA patent/SG10202001501QA/en unknown
- 2016-08-18 HK HK18112326.0A patent/HK1252967A1/zh unknown
- 2016-08-18 CN CN201680048197.3A patent/CN107921110B/zh not_active Expired - Fee Related
- 2016-08-18 MX MX2018002106A patent/MX2018002106A/es unknown
- 2016-08-18 EA EA201890527A patent/EA037295B1/ru not_active IP Right Cessation
- 2016-08-18 MY MYPI2018700619A patent/MY195389A/en unknown
- 2016-08-18 WO PCT/EP2016/069618 patent/WO2017029360A1/en not_active Ceased
- 2016-08-18 EP EP16754488.1A patent/EP3337500A1/en not_active Withdrawn
- 2016-08-19 US US15/242,383 patent/US9790256B2/en not_active Expired - Fee Related
- 2016-08-19 TW TW105126834A patent/TWI744246B/zh not_active IP Right Cessation
- 2016-08-21 JO JOP/2016/0189A patent/JO3765B1/ar active
-
2017
- 2017-09-12 US US15/701,872 patent/US10287323B2/en active Active
-
2018
- 2018-02-16 CL CL2018000432A patent/CL2018000432A1/es unknown
- 2018-02-19 ZA ZA2018/01119A patent/ZA201801119B/en unknown
- 2018-02-19 IL IL257604A patent/IL257604A/en unknown
- 2018-02-19 SA SA518390954A patent/SA518390954B1/ar unknown
- 2018-02-20 CO CONC2018/0001623A patent/CO2018001623A2/es unknown
-
2019
- 2019-01-18 JP JP2019006734A patent/JP6748240B2/ja not_active Expired - Fee Related
- 2019-03-19 US US16/357,493 patent/US10844096B2/en not_active Expired - Fee Related
- 2019-05-03 AU AU2019203124A patent/AU2019203124B2/en not_active Ceased
- 2019-07-18 ZA ZA2019/04717A patent/ZA201904717B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019068852A5 (https=) | ||
| JP2018148890A5 (https=) | ||
| US8337859B2 (en) | Vectors for multiple gene expression | |
| EP2118292B1 (en) | Papillomavirus e2 polypeptide used for vaccination | |
| RU2008145712A (ru) | Вакцина против папилломовирусной инфекции на основе вируса папиломы человека впч-16 | |
| JP2010516287A5 (https=) | ||
| JP2020519614A5 (https=) | ||
| US20100055069A1 (en) | Hpv-18-based papillomavirus vaccines | |
| CN107080833A (zh) | 作为广谱人类乳头状瘤病毒（hpv）疫苗的乳头状瘤病毒样颗粒（vlp） | |
| JP2019514943A5 (https=) | ||
| CN101952320B (zh) | 具有免疫原性的物质 | |
| RU2005109155A (ru) | Днк-вакцина, кодирующая по меньшей мере два неструктурных ранних белка вируса папилломы | |
| CN119736337A (zh) | Matv51重组腺病毒载体、应用、制备方法及hpv16/18/52治疗性疫苗 | |
| JP2002532434A5 (https=) | ||
| JP2006516386A5 (https=) | ||
| AbouZaid | Oncogenic viruses and cancer: a review of literature on their global burden | |
| US6926897B1 (en) | Medicament for the avoidance or treatment of papillomavirus-specific tumour | |
| US20250041399A1 (en) | Cmv-based human papillomavirus vaccines | |
| AU3521499A (en) | Medicament for preventing or treating papilloma virus-specific tumors | |
| Guo et al. | Development Status and trend of HPV vaccine | |
| HK1135731B (en) | Vectors for multiple gene expression | |
| JPWO2023070109A5 (https=) | ||
| AU2013201033A1 (en) | Papillomavirus E2 Polypeptide Used for Vaccination |